Structures by: Razak I. A.
Total: 228
(<i>E</i>)-1-(3-Hydroxyphenyl)-3-[4-(tetradecyloxy)phenyl]prop-2-en-1-one
C29H40O3
Acta Crystallographica Section E (2012) 68, 10 o2911-o2912
a=6.5138(16)Å b=10.155(2)Å c=19.264(5)Å
α=75.361(6)° β=85.872(7)° γ=83.013(6)°
4-Chloro-6-methoxypyrimidin-2-amine
C5H6ClN3O
Acta Crystallographica Section E (2012) 68, 12 o3318
a=3.7683(2)Å b=16.4455(2)Å c=10.7867(2)Å
α=90.00° β=94.5500(10)° γ=90.00°
4,6-Dimethoxy-2-(methylsulfanyl)pyrimidine--4-hydroxybenzoic acid (1/1)
C7H10N2O2S,C7H6O3
Acta Crystallographica Section E (2012) 68, 12 o3415-o3416
a=6.9923(5)Å b=10.2887(8)Å c=10.7578(8)Å
α=77.419(2)° β=83.381(2)° γ=89.209(2)°
2,6-Diamino-4-chloropyrimidine--benzoic acid (1/1)
C4H5ClN4,C7H6O2
Acta Crystallographica Section E (2012) 68, 12 o3442-o3443
a=8.7817(17)Å b=5.7032(12)Å c=24.026(4)Å
α=90.00° β=95.493(4)° γ=90.00°
4-Chloro-6-methoxypyrimidin-2-amine--succinic acid (2/1)
2(C5H6ClN3O),C4H6O4
Acta Crystallographica Section E (2012) 68, 12 o3343
a=5.0094(2)Å b=8.5459(4)Å c=10.8736(5)Å
α=82.3370(10)° β=88.9520(10)° γ=86.9040(10)°
2-Amino-5-methylpyridinium trifluoroacetate
C6H9N2,C2F3O2
Acta Crystallographica Section E (2012) 68, 12 o3319-o3320
a=18.725(4)Å b=4.6256(10)Å c=11.319(2)Å
α=90.00° β=90.00° γ=90.00°
3-{5-Ethoxycarbonyl-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1<i>H</i>- benzimidazol-2-yl}benzoic acid
C24H25N3O5
Acta Crystallographica Section E (2013) 69, 2 o304
a=9.3097(3)Å b=24.8252(7)Å c=9.6761(3)Å
α=90.00° β=112.3220(10)° γ=90.00°
5-Amino-6-methylquinolin-1-ium hydrogen malonate--malonic acid (2/1)
2(C10H11N2),2(C3H3O4),C3H4O4
Acta Crystallographica Section E (2013) 69, 3 o319-o320
a=24.701(2)Å b=4.8530(4)Å c=25.063(2)Å
α=90.00° β=95.321(3)° γ=90.00°
2-Amino-6-methylpyridinium 3-chlorobenzoate
C6H9N2,C7H4ClO2
Acta Crystallographica Section E (2013) 69, 3 o318
a=22.3118(15)Å b=15.2053(10)Å c=7.4166(5)Å
α=90.00° β=100.9240(10)° γ=90.00°
N-Boc-L-pyroglutamic acid ethyl ester
C12H19NO5
Acta Crystallographica Section E (2013) 69, 4 o567-o568
a=26.6884(13)Å b=5.7650(3)Å c=8.7054(4)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-5-bromopyridinium 5-chloro-2-hydroxybenzoate
C5H6BrN2,C7H4ClO3
Acta Crystallographica Section E (2013) 69, 4 o537-o538
a=8.9769(17)Å b=5.6601(12)Å c=12.753(2)Å
α=90.00° β=90.662(5)° γ=90.00°
5-Amino-6-methylquinolin-1-ium 3-carboxypropanoate
C10H11N2,C4H5O4
Acta Crystallographica Section E (2013) 69, 4 o539-o540
a=8.0784(3)Å b=10.8234(4)Å c=16.4366(6)Å
α=91.608(2)° β=101.039(2)° γ=105.782(2)°
<i>N</i>-<i>tert</i>-Butoxycarbonyl-α-(2-fluorobenzyl)-<i>L</i>-proline
C17H22FNO4
Acta Crystallographica Section E (2013) 69, 8 o1297
a=10.47770(10)Å b=12.4283(2)Å c=13.1550(2)Å
α=90.00° β=90.00° γ=90.00°
2,2-Diphenyl-<i>N</i>-{[2-(trifluoromethyl)phenyl]carbamothioyl}acetamide
C22H17F3N2OS
Acta Crystallographica Section E (2013) 69, 8 o1255-o1256
a=20.0318(4)Å b=10.2866(2)Å c=9.5351(2)Å
α=90.00° β=90.00° γ=90.00°
1-[5-(2<i>H</i>-1,3-Benzodioxol-5-yl)-3-(4-methylphenyl)-2-pyrazolin-1-yl]ethanone
C19H18N2O3
Acta Crystallographica Section E (2013) 69, 5 o726
a=7.95640(10)Å b=24.1170(4)Å c=8.46600(10)Å
α=90.00° β=105.3800(10)° γ=90.00°
<i>N</i>-[(2,6-Diethylphenyl)carbamothioyl]-2,2-diphenylacetamide
C25H26N2OS
Acta Crystallographica Section E (2013) 69, 6 o967
a=8.00910(10)Å b=11.7289(2)Å c=11.8923(2)Å
α=79.0080(10)° β=80.6280(10)° γ=83.9360(10)°
3-(<i>p</i>-Tolyl)-sydnone-4-thiosemicarbazone 1,4-dioxane hemisolvate
C11H11N5O2S,0.5(C4H8O2)
Acta Crystallographica Section E (2013) 69, 5 o727
a=7.74630(10)Å b=9.37760(10)Å c=10.4449(2)Å
α=79.6890(10)° β=87.1680(10)° γ=87.4610(10)°
Ethyl 2-[4-(dimethylamino)phenyl]-1-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C24H23N3O2
Acta Crystallographica Section E (2013) 69, 6 o886
a=8.71960(10)Å b=10.4133(2)Å c=11.3658(2)Å
α=79.3120(10)° β=74.3930(10)° γ=89.7810(10)°
6-(4-Methylphenyl)-1,3,5-triazine-2,4-diamine--benzoic acid (1/1)
C10H11N5,C7H6O2
Acta Crystallographica Section E (2013) 69, 6 o968-o969
a=7.4324(5)Å b=10.9717(3)Å c=11.2267(3)Å
α=117.2020(10)° β=101.645(2)° γ=94.032(2)°
6-(4-Methylphenyl)-1,3,5-triazine-2,4-diamine--4-methylbenzoic acid (1/1)
C10H11N5,C8H8O2
Acta Crystallographica Section E (2013) 69, 6 o970
a=11.1271(3)Å b=20.9492(6)Å c=7.4189(2)Å
α=90.00° β=101.321(2)° γ=90.00°
4'-(4-Fluorophenyl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]-1,3,1''-trione methanol hemisolvate
C29H24FNO5,0.5(CH4O)
Acta Crystallographica Section E (2013) 69, 5 o746-o747
a=14.6385(6)Å b=12.5099(6)Å c=26.2017(10)Å
α=90.00° β=92.6450(10)° γ=90.00°
Ethyl 2-[5-(4-fluorophenyl)pyridine-3-yl]-1-[3-(2-oxopyrrolidin-1-yl)propyl] -1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxylate
C28H27FN4O3,H2O
Acta Crystallographica Section E (2013) 69, 7 o1013-o1014
a=16.0640(15)Å b=7.6562(7)Å c=20.1991(19)Å
α=90.00° β=98.163(2)° γ=90.00°
2-Amino-5-methylpyridinium 3-hydroxypyridine-2-carboxylate
C6H9N2,C6H4NO3
Acta Crystallographica Section E (2013) 69, 7 o1118-o1119
a=7.3443(4)Å b=16.4321(9)Å c=10.8235(5)Å
α=90.00° β=118.250(3)° γ=90.00°
2-Amino-4-methylpyridinium 3-hydroxybenzoate
C6H9N2,C7H5O3
Acta Crystallographica Section E (2013) 69, 7 o1120
a=15.4435(2)Å b=15.4435(2)Å c=21.0395(3)Å
α=90.00° β=90.00° γ=90.00°
9-Benzyl-6-benzylsulfanyl-9<i>H</i>-purin-2-amine
C19H17N5S
Acta Crystallographica Section E (2014) 70, 3 o288
a=16.7346(7)Å b=5.5511(3)Å c=20.4817(10)Å
α=90.00° β=121.325(3)° γ=90.00°
Di(N-cyclohexyl-N-ethyldithiocarbamato)lead(II)
(C9H16NS2)2,Pb
Acta Crystallographica Section E (2001) 57, 1 m35-m36
a=9.7180(2)Å b=10.1871(2)Å c=11.8751(3)Å
α=95.5860(10)° β=92.9780(10)° γ=99.1420(10)°
2,3-Diaminopyridinium 4-methoxyquinoline-2-carboxylate
C5H8N3,C11H8NO3
Acta Crystallographica Section E (2012) 68, 12 o3444-o3445
a=12.4338(12)Å b=7.7462(7)Å c=19.4626(14)Å
α=90.00° β=128.806(4)° γ=90.00°
C16H14N2S3
C16H14N2S3
Zeitschrift für Kristallographie - New Crystal Structures (2000) 215, 4 485-486
a=8.7643(1)Å b=10.3305(2)Å c=36.0581(1)Å
α=90.00° β=90.00° γ=90.00°